Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John Trizzino. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John Trizzino har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NVAX / Novavax, Inc. | President and COO | 68 061 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John Trizzino. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NVAX / Novavax, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NVAX / Novavax, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NVAX / Novavax, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John Trizzino som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-11 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −13 954 | 68 061 | −17,01 | 8,34 | −116 376 | 567 629 | |
2025-03-11 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 28 890 | 82 015 | 54,38 | ||||
2025-03-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −23 185 | 53 125 | −30,38 | 8,33 | −193 131 | 442 531 | |
2025-03-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 48 000 | 76 310 | 169,55 | ||||
2024-08-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −317 | 28 310 | −1,11 | 13,90 | −4 406 | 393 509 | |
2024-08-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 655 | 28 627 | 2,34 | ||||
2024-03-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −2 226 | 27 972 | −7,37 | 5,45 | −12 132 | 152 447 | |
2024-03-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 4 608 | 30 198 | 18,01 | ||||
2024-03-11 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −13 955 | 25 590 | −35,29 | 5,61 | −78 288 | 143 560 | |
2024-03-11 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 28 890 | 39 545 | 271,14 | ||||
2023-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −773 | 10 655 | −6,76 | 5,69 | −4 398 | 60 627 | |
2023-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 600 | 11 428 | 16,28 | ||||
2023-08-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −317 | 9 828 | −3,12 | 7,14 | −2 263 | 70 172 | |
2023-08-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 655 | 10 145 | 6,90 | ||||
2023-06-27 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −403 | 9 490 | −4,07 | 6,70 | −2 700 | 63 583 | |
2023-06-27 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 833 | 9 893 | 9,19 | ||||
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −2 471 | 9 060 | −21,43 | 6,52 | −16 111 | 59 071 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 4 609 | 11 531 | 66,58 | 6,52 | 30 051 | 75 182 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −773 | 6 922 | −10,05 | 17,23 | −13 319 | 119 266 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 600 | 7 695 | 26,25 | ||||
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 709 | 6 095 | −21,90 | 18,87 | −32 249 | 115 013 | |
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 538 | 7 804 | 82,93 | ||||
2022-08-23 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −317 | 4 266 | −6,92 | 36,22 | −11 482 | 154 515 | |
2022-08-23 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 655 | 4 583 | 16,68 | ||||
2022-06-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −278 | 3 928 | −6,61 | 51,67 | −14 364 | 202 960 | |
2022-06-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 833 | 4 206 | 24,70 | ||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 13 825 | 13 825 | |||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 20 737 | 20 737 | |||||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −1 600 | 3 200 | −33,33 | ||||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −773 | 3 373 | −18,64 | 168,43 | −130 196 | 568 114 | |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 600 | 4 146 | 62,84 | ||||
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 501 | 95 000 | −7,32 | |||
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −156 | 2 546 | −5,77 | 230,00 | −35 880 | 585 574 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −323 | 2 702 | −10,68 | 228,25 | −73 725 | 616 736 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −148 | 3 025 | −4,66 | 224,24 | −33 187 | 678 325 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −255 | 3 173 | −7,44 | 222,86 | −56 830 | 707 144 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −49 | 3 428 | −1,41 | 220,22 | −10 791 | 754 920 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −421 | 3 477 | −10,80 | 219,26 | −92 310 | 762 381 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −226 | 3 898 | −5,48 | 218,13 | −49 297 | 850 265 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −247 | 4 124 | −5,65 | 216,21 | −53 404 | 891 648 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −318 | 4 371 | −6,78 | 214,65 | −68 258 | 938 224 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −30 | 4 689 | −0,64 | 213,11 | −6 393 | 999 273 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 719 | −2,08 | 211,45 | −21 145 | 997 833 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −112 | 4 819 | −2,27 | 209,57 | −23 472 | 1 009 918 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −312 | 4 931 | −5,95 | 208,46 | −65 038 | 1 027 900 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −382 | 5 243 | −6,79 | 207,32 | −79 196 | 1 086 974 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −990 | 5 625 | −14,97 | 206,30 | −204 240 | 1 160 453 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 452 | 6 615 | −18,00 | 205,25 | −298 029 | 1 357 756 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 141 | 8 067 | −12,39 | 204,12 | −232 904 | 1 646 660 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −839 | 9 208 | −8,35 | 203,26 | −170 537 | 1 871 644 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 501 | 10 047 | 294,62 | 19,08 | 143 119 | 191 697 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 501 | 102 501 | −6,82 | |||
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −70 | 2 546 | −2,68 | 249,04 | −17 433 | 634 056 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −297 | 2 616 | −10,20 | 248,16 | −73 703 | 649 178 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 2 913 | −3,32 | 246,49 | −24 649 | 718 025 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −212 | 3 013 | −6,57 | 244,99 | −51 938 | 738 162 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −53 | 3 225 | −1,62 | 243,20 | −12 890 | 784 327 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −114 | 3 278 | −3,36 | 240,60 | −27 428 | 788 687 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −569 | 3 392 | −14,37 | 239,71 | −136 397 | 813 110 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 3 961 | −2,46 | 237,58 | −23 758 | 941 054 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −267 | 4 061 | −6,17 | 236,75 | −63 211 | 961 422 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −369 | 4 328 | −7,86 | 235,77 | −86 999 | 1 020 414 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −849 | 4 697 | −15,31 | 234,37 | −198 984 | 1 100 858 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 270 | 5 546 | −18,63 | 233,25 | −296 225 | 1 293 593 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −924 | 6 816 | −11,94 | 231,95 | −214 322 | 1 580 975 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 365 | 7 740 | −14,99 | 231,16 | −315 530 | 1 789 159 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −628 | 9 105 | −6,45 | 230,19 | −144 558 | 2 095 856 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −314 | 9 733 | −3,13 | 228,69 | −71 807 | 2 225 803 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 501 | 10 047 | 294,62 | 19,08 | 143 119 | 191 697 |
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −3 537 | 3 538 | −49,99 | ||||
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 709 | 2 546 | −40,16 | 248,16 | −424 105 | 631 815 | |
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 537 | 4 255 | 492,62 | ||||
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 500 | 110 002 | −6,38 | |||
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −368 | 718 | −33,89 | 231,11 | −85 050 | 165 939 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 515 | 1 086 | −58,25 | 230,31 | −348 923 | 250 119 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −726 | 2 601 | −21,82 | 229,03 | −166 278 | 595 714 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −853 | 3 327 | −20,41 | 228,22 | −194 674 | 759 295 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −585 | 4 180 | −12,28 | 227,09 | −132 845 | 949 217 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 365 | 4 765 | −22,27 | 226,24 | −308 821 | 1 078 046 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 269 | 6 130 | −17,15 | 224,79 | −285 262 | 1 377 980 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −819 | 7 399 | −9,97 | 223,95 | −183 413 | 1 656 984 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 500 | 8 218 | 1 044,57 | 19,08 | 143 100 | 156 799 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 500 | 117 502 | −6,00 | |||
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −112 | 718 | −13,49 | 232,90 | −26 084 | 167 219 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −256 | 830 | −23,57 | 231,90 | −59 366 | 192 475 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −755 | 1 086 | −41,01 | 230,69 | −174 167 | 250 524 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −918 | 1 841 | −33,27 | 229,92 | −211 063 | 423 276 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 307 | 2 759 | −32,14 | 228,72 | −298 935 | 631 033 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −578 | 4 066 | −12,45 | 227,87 | −131 710 | 926 531 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 175 | 4 644 | −20,19 | 226,65 | −266 311 | 1 052 551 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 032 | 5 819 | −15,06 | 225,68 | −232 905 | 1 313 249 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −705 | 6 851 | −9,33 | 224,77 | −158 460 | 1 539 867 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −662 | 7 556 | −8,06 | 223,18 | −147 747 | 1 686 373 |
2021-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 500 | 8 218 | 1 044,57 | 19,08 | 143 100 | 156 799 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 499 | 125 002 | −5,66 | |||
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −216 | 718 | −23,13 | 241,70 | −52 208 | 173 542 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −590 | 934 | −38,71 | 240,37 | −141 819 | 224 506 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −564 | 1 524 | −27,01 | 238,95 | −134 768 | 364 160 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 423 | 2 088 | −40,53 | 238,10 | −338 821 | 497 159 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −799 | 3 511 | −18,54 | 237,14 | −189 474 | 832 593 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 422 | 4 310 | −24,81 | 236,16 | −335 826 | 1 017 869 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −682 | 5 732 | −10,63 | 235,16 | −160 377 | 1 347 920 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −905 | 6 414 | −12,37 | 233,90 | −211 680 | 1 500 238 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −898 | 7 319 | −10,93 | 233,17 | −209 389 | 1 706 587 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 499 | 8 217 | 1 044,43 | 19,08 | 143 081 | 156 780 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −7 499 | 132 501 | −5,36 | |||
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −244 | 718 | −25,36 | 247,33 | −60 349 | 177 583 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −333 | 962 | −25,71 | 245,16 | −81 638 | 235 844 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −74 | 1 295 | −5,41 | 242,62 | −17 954 | 314 194 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −66 | 1 369 | −4,60 | 238,13 | −15 716 | 325 994 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −493 | 1 435 | −25,57 | 237,84 | −117 255 | 341 301 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −880 | 1 928 | −31,34 | 236,38 | −208 015 | 455 742 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 293 | 2 808 | −31,53 | 235,50 | −304 506 | 661 294 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 091 | 4 101 | −21,01 | 234,26 | −255 582 | 960 717 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 279 | 5 192 | −19,77 | 233,25 | −298 326 | 1 211 032 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 317 | 6 471 | −16,91 | 232,24 | −305 866 | 1 502 854 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −429 | 7 788 | −5,22 | 231,29 | −99 225 | 1 801 322 |
2021-09-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 7 499 | 8 217 | 1 044,43 | 19,08 | 143 081 | 156 780 |
2021-08-20 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 1 965 | 1 965 | |||||
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −834 | 1 666 | −33,36 | ||||
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −403 | 718 | −35,95 | 189,79 | −76 485 | 136 269 | |
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 834 | 1 121 | 290,59 | ||||
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −90 | 287 | −23,87 | 176,60 | −15 894 | 50 684 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 377 | −20,96 | 176,65 | −17 665 | 66 597 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −384 | 11 117 | −3,34 | |||
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 084 | 60 417 | −3,33 | |||
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 10 423 | −4,76 | |||
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 3 341 | −11,10 | |||
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −180 | 477 | −27,40 | 171,74 | −30 913 | 81 920 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −14 | 657 | −2,09 | 171,74 | −2 404 | 112 833 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 384 | 671 | 133,80 | 5,95 | 2 285 | 3 992 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −68 | 287 | −19,15 | 194,08 | −13 198 | 55 702 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −246 | 355 | −40,93 | 192,81 | −47 431 | 68 448 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −412 | 601 | −40,67 | 191,53 | −78 909 | 115 107 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −192 | 1 013 | −15,93 | 190,62 | −36 599 | 193 098 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −364 | 1 205 | −23,20 | 189,46 | −68 962 | 228 295 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −318 | 1 569 | −16,85 | 188,51 | −59 945 | 295 766 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −186 | 1 887 | −8,97 | 187,35 | −34 848 | 353 539 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −105 | 2 073 | −4,82 | 186,05 | −19 536 | 385 689 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −252 | 2 178 | −10,37 | 184,25 | −46 430 | 401 288 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −138 | 2 430 | −5,37 | 183,43 | −25 313 | 445 728 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −160 | 2 568 | −5,87 | 182,45 | −29 192 | 468 525 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −85 | 2 728 | −3,02 | 181,17 | −15 399 | 494 221 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −70 | 2 813 | −2,43 | 180,37 | −12 626 | 507 377 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −28 | 2 883 | −0,96 | 171,89 | −4 813 | 495 567 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −208 | 2 911 | −6,67 | 171,09 | −35 586 | 498 032 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −93 | 3 119 | −2,90 | 169,70 | −15 782 | 529 293 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −13 | 3 212 | −0,40 | 168,34 | −2 188 | 540 696 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −12 | 3 225 | −0,37 | 164,71 | −1 977 | 531 190 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −72 | 3 237 | −2,18 | 163,03 | −11 738 | 527 717 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 084 | 3 309 | 170,12 | 5,95 | 12 400 | 19 689 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 1 225 | 74,01 | 46,00 | 23 966 | 56 350 |
2021-05-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 704 | 145,30 | 27,60 | 11 509 | 19 430 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −191 | 287 | −39,96 | 178,03 | −34 004 | 51 095 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −383 | 11 501 | −3,22 | |||
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 083 | 62 501 | −3,23 | |||
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 10 944 | −4,54 | |||
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 3 758 | −9,99 | |||
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −179 | 478 | −27,25 | 177,29 | −31 735 | 84 745 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −13 | 657 | −1,94 | 177,29 | −2 305 | 116 480 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 383 | 670 | 133,45 | 177,29 | 67 902 | 118 784 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 021 | 287 | −91,32 | 190,10 | −574 292 | 54 559 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 083 | 3 308 | 170,04 | 5,95 | 12 394 | 19 683 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 1 225 | 74,01 | 46,00 | 23 966 | 56 350 |
2021-04-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 704 | 145,30 | 27,60 | 11 509 | 19 430 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −190 | 287 | −39,83 | 168,09 | −31 937 | 48 242 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −383 | 11 884 | −3,12 | |||
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 083 | 64 584 | −3,12 | |||
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 11 465 | −4,35 | |||
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 4 175 | −9,08 | |||
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −179 | 477 | −27,29 | 174,84 | −31 296 | 83 399 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −14 | 656 | −2,09 | 174,84 | −2 448 | 114 695 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 383 | 670 | 133,45 | 5,95 | 2 279 | 3 986 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −12 | 287 | −4,01 | 175,16 | −2 102 | 50 271 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −186 | 299 | −38,35 | 173,54 | −32 278 | 51 888 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −203 | 485 | −29,51 | 172,24 | −34 964 | 83 535 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −314 | 688 | −31,34 | 171,23 | −53 767 | 117 808 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −336 | 1 002 | −25,11 | 170,25 | −57 206 | 170 595 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −91 | 1 338 | −6,37 | 168,89 | −15 369 | 225 978 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −167 | 1 429 | −10,46 | 167,73 | −28 011 | 239 685 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −263 | 1 596 | −14,15 | 166,48 | −43 784 | 265 700 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −162 | 1 859 | −8,02 | 163,53 | −26 492 | 304 001 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −172 | 2 021 | −7,84 | 160,82 | −27 661 | 325 022 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −101 | 2 193 | −4,40 | 159,02 | −16 061 | 348 739 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −160 | 2 294 | −6,52 | 157,08 | −25 133 | 360 342 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −135 | 2 454 | −5,21 | 155,64 | −21 011 | 381 941 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −185 | 2 589 | −6,67 | 154,00 | −28 490 | 398 712 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −312 | 2 774 | −10,11 | 153,24 | −47 812 | 425 101 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −150 | 3 086 | −4,64 | 152,39 | −22 859 | 470 289 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −72 | 3 236 | −2,18 | 150,31 | −10 822 | 486 409 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 083 | 3 308 | 170,04 | 5,95 | 12 394 | 19 683 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 1 225 | 74,01 | 46,00 | 23 966 | 56 350 |
2021-03-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 704 | 145,30 | 27,60 | 11 509 | 19 430 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −194 | 287 | −40,33 | 324,50 | −62 953 | 93 132 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −384 | 12 267 | −3,04 | |||
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 084 | 66 667 | −3,03 | |||
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 11 986 | −4,17 | |||
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 4 592 | −8,33 | |||
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −182 | 481 | −27,45 | 290,18 | −52 813 | 139 577 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −8 | 663 | −1,19 | 290,18 | −2 321 | 192 389 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 384 | 671 | 133,80 | 5,95 | 2 285 | 3 992 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −25 | 287 | −8,01 | 298,80 | −7 470 | 85 756 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −30 | 312 | −8,77 | 297,82 | −8 935 | 92 920 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −104 | 342 | −23,32 | 296,96 | −30 884 | 101 562 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −238 | 446 | −34,80 | 296,01 | −70 451 | 132 022 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −625 | 684 | −47,75 | 295,05 | −184 404 | 201 811 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −405 | 1 309 | −23,63 | 293,96 | −119 054 | 384 793 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −272 | 1 714 | −13,70 | 292,91 | −79 670 | 502 040 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −117 | 1 986 | −5,56 | 291,79 | −34 139 | 579 490 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 2 103 | −2,64 | 290,86 | −16 579 | 611 688 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −55 | 2 160 | −2,48 | 289,45 | −15 920 | 625 202 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −30 | 2 215 | −1,34 | 287,03 | −8 611 | 635 771 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −25 | 2 245 | −1,10 | 284,82 | −7 120 | 639 421 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 020 | 2 270 | −31,00 | 283,50 | −289 171 | 643 548 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −19 | 3 290 | −0,57 | 282,00 | −5 358 | 927 791 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 084 | 3 309 | 170,12 | 5,95 | 12 400 | 19 689 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 1 225 | 74,01 | 46,00 | 23 966 | 56 350 |
2021-02-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 704 | 145,30 | 27,60 | 11 509 | 19 430 |
2021-01-27 |
|
4/A | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −511 | 866 | −37,11 | 116,24 | −59 399 | 100 664 |
2021-01-27 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −73 | 287 | −20,28 | 128,60 | −9 388 | 36 909 |
2021-01-27 |
|
4/A | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −73 | 287 | −20,28 | 128,60 | −9 388 | 36 909 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −506 | 287 | −63,81 | 124,17 | −62 830 | 35 637 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −1 149 | 12 651 | −8,33 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −6 249 | 68 751 | −8,33 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 082 | 12 507 | −14,27 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 668 | 5 009 | −24,98 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 214 | 0 | −100,00 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −394 | 0 | −100,00 | |||
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −584 | 793 | −42,41 | 116,24 | −67 884 | 92 178 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −59 | 1 377 | −4,11 | 116,24 | −6 858 | 160 062 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 149 | 1 436 | 400,35 | 5,95 | 6 837 | 8 544 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −349 | 287 | −54,87 | 115,11 | −40 172 | 33 035 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 500 | 636 | −70,22 | 114,25 | −171 378 | 72 664 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 500 | 2 136 | −62,10 | 113,29 | −396 511 | 241 985 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 194 | 5 636 | −42,67 | 112,19 | −470 525 | 632 303 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 164 | 9 830 | −29,76 | 111,19 | −463 003 | 1 093 015 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 700 | 13 994 | −20,91 | 110,25 | −407 934 | 1 542 872 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 6 249 | 17 694 | 54,60 | 5,95 | 37 182 | 105 279 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 082 | 11 445 | 22,24 | 46,00 | 95 772 | 526 470 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 668 | 9 363 | 21,68 | 27,60 | 46 037 | 258 419 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 214 | 7 695 | 40,39 | 27,00 | 59 778 | 207 765 |
2021-01-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 394 | 5 481 | 7,75 | 27,00 | 10 638 | 147 987 |
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 4 800 | 4 800 | |||||
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 9 500 | 9 500 | |||||
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −109 | 5 087 | −2,10 | 115,08 | −12 544 | 585 427 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −214 | 5 196 | −3,96 | 114,03 | −24 402 | 592 493 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −58 | 5 410 | −1,06 | 112,78 | −6 541 | 610 140 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −160 | 5 468 | −2,84 | 112,03 | −17 925 | 612 582 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −332 | 5 628 | −5,57 | 110,85 | −36 802 | 623 862 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −353 | 5 960 | −5,59 | 109,59 | −38 686 | 653 174 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −945 | 6 313 | −13,02 | 108,57 | −102 601 | 685 415 |
2020-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −79 | 7 258 | −1,08 | 107,60 | −8 501 | 780 975 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 432 | 7 337 | −24,90 | 109,12 | −265 383 | 800 624 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 751 | 9 769 | −32,72 | 108,08 | −513 480 | 1 055 816 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 653 | 14 520 | −28,02 | 107,05 | −605 133 | 1 554 312 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 485 | 20 173 | −21,38 | 106,04 | −581 634 | 2 139 163 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 600 | 13 800 | −25,00 | |||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 75 000 | −25,00 | |||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −551 | 25 658 | −2,10 | 117,07 | −64 548 | 3 003 669 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −951 | 26 210 | −3,50 | 116,08 | −110 346 | 3 042 378 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 003 | 27 160 | −3,56 | 115,23 | −115 521 | 3 129 690 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −401 | 28 163 | −1,40 | 113,81 | −45 639 | 3 205 324 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −727 | 28 564 | −2,48 | 113,02 | −82 148 | 3 228 418 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −216 | 29 291 | −0,73 | 111,92 | −24 124 | 3 278 354 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 343 | 29 506 | −7,36 | 110,97 | −260 024 | 3 274 393 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −8 133 | 31 849 | −20,34 | 109,98 | −894 440 | 3 502 718 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −6 661 | 39 982 | −14,28 | 109,07 | −726 546 | 4 360 761 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 739 | 46 643 | −7,42 | 108,20 | −404 560 | 5 046 642 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −276 | 50 383 | −0,54 | 107,22 | −29 560 | 5 402 101 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 103 | 50 658 | −3,99 | 111,18 | −233 812 | 5 632 156 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −247 | 52 761 | −0,47 | 111,18 | −27 461 | 5 865 968 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 600 | 53 008 | 9,50 | 5,95 | 27 370 | 315 398 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 25 000 | 48 408 | 106,80 | 5,95 | 148 750 | 288 028 |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −3 538 | 7 076 | −33,33 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −31 900 | 0 | −100,00 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 709 | 23 408 | −6,80 | 113,56 | −194 074 | 2 658 212 | |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 538 | 25 117 | 16,40 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −15 408 | 21 579 | −41,66 | 113,56 | −1 749 732 | 2 450 511 | |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 31 900 | 36 987 | 627,09 | ||||
2020-08-26 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 140 000 | 140 000 | |||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −10 410 | 14 589 | −41,64 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −13 322 | 6 677 | −66,61 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −1 952 | 4 298 | −31,23 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −5 855 | 394 | −93,69 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −11 249 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −1 300 | 5 087 | −20,35 | 153,95 | −200 135 | 783 144 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −1 708 | 6 387 | −21,10 | 153,16 | −261 597 | 978 233 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −4 199 | 8 095 | −34,15 | 152,22 | −639 172 | 1 232 221 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −4 010 | 12 294 | −24,60 | 150,85 | −604 908 | 1 854 550 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −1 800 | 16 304 | −9,94 | 149,83 | −269 694 | 2 442 828 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −6 600 | 18 104 | −26,72 | 149,08 | −983 928 | 2 698 944 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −9 101 | 24 704 | −26,92 | 147,99 | −1 346 857 | 3 655 945 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −8 094 | 33 805 | −19,32 | 146,95 | −1 189 413 | 4 967 645 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −4 900 | 41 899 | −10,47 | 146,21 | −716 429 | 6 126 053 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −300 | 46 799 | −0,64 | 143,99 | −43 197 | 6 738 588 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −776 | 47 099 | −1,62 | 142,85 | −110 852 | 6 728 092 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 10 410 | 47 875 | 27,79 | 46,00 | 478 860 | 2 202 250 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 13 322 | 37 465 | 55,18 | 27,60 | 367 687 | 1 034 034 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 952 | 24 143 | 8,80 | 27,00 | 52 704 | 651 861 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 5 855 | 22 191 | 35,84 | 27,00 | 158 085 | 599 157 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 11 249 | 16 336 | 221,13 | 99,80 | 1 122 650 | 1 630 333 | |
2020-06-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 2 500 | 2 500 | |||||
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −468 | 0 | −100,00 | ||||
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −181 | 5 087 | −3,44 | 12,48 | −2 259 | 63 486 | |
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 468 | 5 268 | 9,75 | ||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
A - Award | 18 400 | 18 400 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 10 613 | 10 613 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 31 900 | 31 900 | |||||
2019-09-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −5 578 | 4 800 | −53,75 | 5,72 | −31 911 | 27 460 | |
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −5 143 | 0 | −100,00 | ||||
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 713 | 10 378 | −14,17 | 5,50 | −9 422 | 57 079 | |
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 5 143 | 12 091 | 74,02 | ||||
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 46 887 | 46 887 | |||||
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 102 861 | 102 861 | |||||
2018-12-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 500 000 | 500 000 | |||||
2018-05-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 50 000 | 138 965 | 56,20 | 1,64 | 81 995 | 227 889 | |
2017-12-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 400 000 | 400 000 | |||||
2017-02-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 3 401 | 88 965 | 3,97 | 1,12 | 3 809 | 99 641 | |
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
2016-09-23 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 46 000 | 85 564 | 116,27 | 2,17 | 99 820 | 185 674 | |
2016-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 225 000 | 225 000 | |||||
2016-02-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 5 855 | 39 564 | 17,37 | 3,63 | 21 254 | 143 617 | |
2015-08-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 5 098 | 33 709 | 17,82 | 3,63 | 18 506 | 122 364 | |
2015-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 200 000 | 200 000 | |||||
2015-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 6 611 | 28 611 | 30,05 | 3,63 | 23 998 | 103 858 | |
2014-06-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 5 500 | 22 000 | 33,33 | 4,51 | 24 800 | 99 198 | |
2014-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 700 | 16 500 | 4,43 | 4,59 | 3 213 | 75 735 | |
2014-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 4 800 | 15 800 | 43,64 | 4,59 | 22 027 | 72 506 | |
2014-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 11 000 | 11 000 | 4,47 | 49 214 | 49 214 | ||
2014-03-12 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 300 000 | 300 000 |